Female gender is an independent predictor of clinical benefit from cardiac resynchronisation therapy - results from the BIOWOMEN study

28 August 2023 (16:15 - 16:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Lieselot Van Erven

Leiden University Medical Center, Leiden (Netherlands (The))

6 More presentations in this session

Presentation thumbnail

Biventricular or conduction system pacing for cardiac resynchronization therapy: a proposed treatment algorithm based on interventricular conduction delays

Doctor F. Landra (Cuneo, IT)

Abstract Slides Video

Presentation thumbnail

Associations of 2013 and 2021 ESC definitions of left bundle-branch block with mechanical dyssynchrony and CRT-induced reverse remodeling

Doctor A. Beela (Maastricht, NL)

Abstract Slides Video

Presentation thumbnail

Personalized cardiac resynchronization therapy guided by real-time electrocardiographic imaging for non-left bundle branch block patients

Doctor M. Tam (Shatin, HK)

Abstract Slides Video

Presentation thumbnail

Left ventricular anterolateral site is the preferable left ventricular lead position for an upgrade to biventricular pacing

Doctor M. Ogano (Shizuoka, JP)

Abstract Slides Video

Presentation thumbnail

Fragmented QRS complex as a predictor of all-cause mortality in patients undergoing cardiac resynchronization therapy

Doctor J. Esteban Chapel (Madrid, ES)

Abstract Slides Video

Access the full session

Session thumbnail

New insights into cardiac resynchronisation therapy and remote monitoring

The Event

Event poster

ESC Congress 2023

28 August 2023 16:15 CET

You may be interested in

Congress Session

Ventricular storm (2)

Congress Session

Navigating through heart failure device therapies

Congress Session

Conduction system pacing in challenging settings

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources